(Press-News.org) A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.
The preventive therapy will "optimize care for hemophilia patients of all ages by stopping unexpected bleeding events that can have a detrimental impact on the lives of patients," said Dr. Leonard Valentino, director of the Rush Hemophilia and Thrombophilia Center and principal investigator on the study. The study results appeared in the January online version of the Journal of Thrombosis and Haemostasis. Valentino is associate professor of Pediatrics at Rush University's Rush Medical College.
The study, sponsored by Baxter Healthcare Corporation, was conducted as part of a comprehensive clinical study of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) to compare the effectiveness of two prophylactic treatment regimens, as well as between on-demand and prophylaxis treatments, in preventing bleeding in previously treated patients with severe or moderately severe hemophilia A. It is the first study designed to generate prospective data for stringent comparisons of bleeding rates.
Hemophilia A is a rare, inherited, potentially deadly blood clotting disorder that affects 400,000 people worldwide, most of them males. Approximately one in 5,000 individuals is born with hemophilia annually.
In people with hemophilia A, a protein called clotting factor VIII is either absent or present at low levels. Factor VIII replacement, such as rAHF-PFM, is considered the treatment of choice for managing hemophilia A patients who lack inhibitors (antibodies) of factor VIII.
About 90 percent of people who have hemophilia have type A. Of these, 70 percent have the severe form of the disorder, indicated by a factor VIII level of less than 1 percent of normal.
Patients with severe disease are at particular risk for spontaneous bleeding into joints, muscles and internal organs, as well as trauma-induced bleeding following injury and surgery. Joint bleeding may occur as frequently as 20 to 30 times a year, resulting in clinically significant hemophilia-related arthritis.
"The main goal of replacement therapy is to prevent this pathology," Valentino said.
Primary prophylaxis is already the standard of care for children with hemophilia A. It is believed that the early initiation of prophylaxis may confer a protective effect against factor VIII inhibitor, the most serious complication associated with replacement therapy.
Adult hemophilia patients are treated either in response to bleeding (on demand) or with regular infusion of clotting factor to prevent bleeding and further joint damage. However, while on-demand treatment can slow the progression of hemophilia-related arthritis, it does not seem to prevent the condition.
In the Rush study, one regimen was based on common practice with every-other-day dosing. The other was customized for each individual based on the drug's activity in the body (pharmacokinetics, or PK) with every-third-day dosing. PK-tailored prophylaxis offers an alternative to standard prophylaxis for the prevention of bleeding.
Study participants aged 7 to 65 years received six months of on-demand treatment with dosing dependent on the severity and type of bleeding episode. After completing the on-demand treatment period, subjects were randomized to receive 12 months of either standard or PK-tailored prophylaxis treatment. Once the prophylaxis period began, factor VIII levels were assessed every three months.
Of the 66 subjects in the study, 22 (33.3 percent) who received prophylaxis had no bleeding episodes, in contrast to the patients treated on demand. No subject developed factor VIII inhibitors. The patients who achieved these results were adherent to the prescribed number of prophylactic infusions.
Compared with on-demand treatment, both prophylaxis regimens significantly reduced bleeding, including spontaneous and traumatic hemorrhaging, and improved the quality of life for adolescent and adults patients. Results of the study suggest that prophylaxis is the optimal treatment for patients with severe hemophilia. Data from the study also confirm and extend the safety and effectiveness of rAHF-PFM for controlling and preventing bleeding in the management of hemophilia A.
The study findings suggest that the PK-tailored prophylaxis regimen, which used similar amounts of rAHF-PFM and one fewer infusion per week, is a viable treatment alternative to standard prophylaxis. The availability of this option could increase treatment adherence, particularly in children and adolescents, for whom compliance with long-term medical regimens is especially challenging. Additionally, the study confirms and extends the safety and effectiveness of rAHF-PFM for controlling and preventing bleeding in the management of hemophilia A.
INFORMATION:
Valentino's co-researchers on the study were Vasily Mamonov, Hematology Research Center under the Russian Academy of Medical Sciences, Department of Reconstructive Orthopedic Surgery for Hemophilia Patients, Moscow, Russian Federation; Andrzej Hellmann, Department of Hematology and Transplantology, Medical University of Gdańsk, Poland; Doris V. Quon, Orthopaedic Hospital, Hemophilia Treatment Center, Los Angeles; Alicja Chybicka, Wroclaw Medical University, Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw, Poland; and Phillip Schroth, Lisa Patrone, and Wing-Yen Wong, Baxter Healthcare Corporation, Westlake Village, Calif., for the Prophylaxis Study Group.
The Hemophilia and Thrombophilia Center at Rush is the largest hemophilia and thrombophilia program in Illinois. The Center offers clinical and laboratory services onsite for patients with bleeding and clotting disorders.
END
DURHAM, N.C. – Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute.
The Duke team found that noise-cancelling headphones playing a classical melody may reduce the pain and anxiety of the often uncomfortable procedure.
The finding, published this month in the journal Urology, points to a simple and inexpensive way to help an estimated 700,000 U.S. men who undergo a prostate biopsy a year. The procedure is essentially the only way to diagnose prostate cancer, which strikes one in six ...
COLUMBIA, Mo. – As the U.S. economy continues to lag, many investors remain wary about taking risks with the stock market. Now, researchers at the University of Missouri have concluded that this attitude toward investment risk-taking is influenced by the age of the investor and the economic climate of the time period. Rui Yao, an assistant professor of personal financial planning in the College of Human Environmental Sciences at MU, found that willingness to take financial risks, or "risk tolerance," decreases as investors age.
"Age has a pragmatic relationship with financial ...
New York / Heidelberg, 9 January 2012 -- Young female cancer survivors are concerned about their future fertility and parenthood options and want better information and guidance early on, according to a new study by Jessica Gorman and her team from the University of California in the US. Their paper, which presents in-depth information on young survivors' experiences navigating decisions about fertility and parenthood, is published online in Springer's Journal of Cancer Survivorship.
Many more adolescents and young adults are surviving their disease, resulting in a substantial ...
Philadelphia, January 9, 2012 – In the first study to investigate driving as it relates to teens with a high-functioning autism disorder (HFASD), child development and teen driving experts at The Children's Hospital of Philadelphia's Center for Child Injury Prevention Studies found that two-thirds of teenagers with a high-functioning autism spectrum disorder (HFASD) who are of legal driving age in their state are currently driving or plan to drive.
The study is published this month in the Journal of Developmental and Behavioral Pediatrics.
A HFASD is characterized ...
Miguel A. Cazalilla, a scientist at the CFM (a joint CSIC-UPV/EHU center) and the Donostia International Physics Center (DIPC), together with other four colleagues from various institutions in Europe and the United States, was recently invited to write a review article that has been just published in the prestigious journal Reviews of Modern Physics of the American Physical Society, where only leading scientists in their field of physics are invited to contribute. The article, "One dimensional Bosons: From Condensed Matter to Ultracold Atoms", offers a glimpse into the ...
For the first time, astronomers have mapped dark matter on the largest scale ever observed. The results, presented by Dr Catherine Heymans of the University of Edinburgh, Scotland, and Associate Professor Ludovic Van Waerbeke of the University of British Columbia, Vancouver, Canada, are being presented today to the American Astronomical Society meeting in Austin, Texas. Their findings reveal a Universe comprised of an intricate cosmic web of dark matter and galaxies spanning more than one billion light years.
An international team of researchers lead by Van Waerbeke ...
COLUMBUS, Ohio – Researchers are beginning their analysis of what are probably the first successful ice cores drilled to bedrock from a glacier in the eastern European Alps.
With luck, that analysis will yield a record of past climate and environmental changes in the region for several centuries, and perhaps even covering the last 1,000 years. Scientists also hope that the core contains the remnants of early human activity in the region, such as the atmospheric byproducts of smelting metals.
The project, led by a team of Ohio State University scientists and their European ...
CAMBRIDGE, Mass. -- Objects that resemble faces are everywhere. Whether it's New Hampshire's erstwhile granite "Old Man of the Mountain," or Jesus' face on a tortilla, our brains are adept at locating images that look like faces. However, the normal human brain is almost never fooled into thinking such objects actually are human faces.
"You can tell that it has some 'faceness' to it, but on the other hand, you're not misled into believing that it is a genuine face," says Pawan Sinha, professor of brain and cognitive sciences at MIT.
A new study from Sinha and his colleagues ...
(PHILADELPHIA) – Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women. Their study on the role of obesity in cancer screening rates for prostate, cervical as well as breast and colorectal cancers across race/ethnicity and gender is examined in the current issue of the Journal of Obesity.
"Numerous studies have suggested that obesity constitutes an obstacle ...
The James Webb Space Telescope marked a year of significant progress in 2011 as it continues to come together as NASA's next generation space telescope. The year brought forth a pathfinder backplane to support the large primary mirror structure, mirror cryotesting, creation of mirror support structures, several successful sunshield layer tests and the creation of an assembly station within NASA Goddard Space Flight Center's cleanroom. Achievements were also made in the areas of flight and communications software and the propulsion system.
In December, manufacturing and ...
